Definitive radiotherapy consisting of external beam radiotherapy without central shielding and 3D image-guided brachytherapy for patients with cervical cancer: feasibility for Japanese patients and dose-response analyses for local control in the low-dose range

To assess the feasibility of external beam radiotherapy without central shielding in definitive radiotherapy for Japanese patients with cervical cancer. We retrospectively analysed the data of cervical cancer patients treated with definitive radiotherapy consisting of external beam radiotherapy with...

Full description

Saved in:
Bibliographic Details
Published in:Japanese journal of clinical oncology 2023-06, Vol.53 (6), p.480-488
Main Authors: Toita, Takafumi, Wada, Kentaro, Sutani, Shinya, Umezawa, Rei, Maemoto, Hitoshi, Ii, Noriko, Kawamura, Tomoko, Ikushima, Hitoshi, Takenaka, Ryosuke, Konishi, Koji, Yorozu, Atsunori, Jingu, Keiichi, Ariga, Takuro, Nomoto, Yoshihito, Yamashita, Hideomi
Format: Article
Language:English
Subjects:
Brachytherapy
East Asian People
Feasibility Studies
Female
Humans
Radiotherapy Dosage
Radiotherapy, Image-Guided
Retrospective Studies
Treatment Outcome
Uterine Cervical Neoplasms - radiotherapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c347t-9f927870e3c74328977c096c4e4ec4efacbbd83083b885b20207840b6f13bcf73
cites cdi_FETCH-LOGICAL-c347t-9f927870e3c74328977c096c4e4ec4efacbbd83083b885b20207840b6f13bcf73
container_end_page 488
container_issue 6
container_start_page 480
container_title Japanese journal of clinical oncology
container_volume 53
creator Toita, Takafumi
Wada, Kentaro
Sutani, Shinya
Umezawa, Rei
Maemoto, Hitoshi
Ii, Noriko
Kawamura, Tomoko
Ikushima, Hitoshi
Takenaka, Ryosuke
Konishi, Koji
Yorozu, Atsunori
Jingu, Keiichi
Ariga, Takuro
Nomoto, Yoshihito
Yamashita, Hideomi
description To assess the feasibility of external beam radiotherapy without central shielding in definitive radiotherapy for Japanese patients with cervical cancer. We retrospectively analysed the data of cervical cancer patients treated with definitive radiotherapy consisting of external beam radiotherapy without central shielding and three-dimensional-image-guided brachytherapy. The study included 167 patients (T1 + 2 = 108, T3 + 4 = 59) from eight Japanese institutions. For three-dimensional-image-guided brachytherapy, intra-cavitary and interstitial brachytherapy was utilized in 33 patients (20%). The median follow-up was 26.6 months (interquartile range, 20-43.2). The maximum rectal D2 (75 Gy)/bladder D2 (90 Gy) constraints were deviated by 6%/10% and 10%/5% for T1 + 2 and T3 + 4, respectively. The 2-year incidence of ≥grade 3 proctitis/cystitis was 4%/1% for T1 + 2 and 10%/2% for T3 + 4. The 2-year local progression-free survival was 89% for T1 + 2 and 82% for T3 + 4. For T1 + 2, the 2-year local progression-free survival for the high-risk clinical target volume D90 ≥ 68 Gy (indicated by receiver operating characteristic analysis; area under the curve = 0.711) was 92% versus 67% for
doi_str_mv 10.1093/jjco/hyad022
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2821639554</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2821639554</sourcerecordid><originalsourceid>FETCH-LOGICAL-c347t-9f927870e3c74328977c096c4e4ec4efacbbd83083b885b20207840b6f13bcf73</originalsourceid><addsrcrecordid>eNpVkUtv1DAUhQMqog_YsUZesiDUsZM4YYdaXlWlbmAd-XE98chjB9tpyb_HmZkC3djW1XfOvdenKN5U-EOFe3q53Up_OS5cYUKeF2dV3TYlbUl18t_7tDiPcYsxbrqavSxOaduzmlXt2bOTa9DGmWTuAQWujE8jBD4tSHoXTUzGbZDXCH4nCI5bJIDvnoIPJo1-TkiCSyETcTRg1arjTiF6jcyOb6DczEaBQiJwOS6PWu0DmngyWRr3Rtkl3BuZbSR3-f0RaeDRCGNNOuA3fOIOIvzTrW2Uj1AGiFOeGnKF2yVC3Aus39v5PJ23yDiUm-fiQ7lq8ipuA6-KF5rbCK-P90Xx88vnH1ffytu7r9-vPt2WktYslb3uCesYBipZTUnXMyZx38oaasiH5lII1VHcUdF1jSCYYNbVWLS6okJqRi-KdwffKfhfM8Q07EyUYG3eyM9xIB2pWto3TZ3R9wdUBh9jAD1MIX9kWIYKD2vuw5r7cMw942-PzrPYgfoLPwZN_wD2zbIm</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2821639554</pqid></control><display><type>article</type><title>Definitive radiotherapy consisting of external beam radiotherapy without central shielding and 3D image-guided brachytherapy for patients with cervical cancer: feasibility for Japanese patients and dose-response analyses for local control in the low-dose range</title><source>Oxford University Press:Jisc Collections:OUP Read and Publish 2024-2025 (2024 collection) (Reading list)</source><creator>Toita, Takafumi ; Wada, Kentaro ; Sutani, Shinya ; Umezawa, Rei ; Maemoto, Hitoshi ; Ii, Noriko ; Kawamura, Tomoko ; Ikushima, Hitoshi ; Takenaka, Ryosuke ; Konishi, Koji ; Yorozu, Atsunori ; Jingu, Keiichi ; Ariga, Takuro ; Nomoto, Yoshihito ; Yamashita, Hideomi</creator><creatorcontrib>Toita, Takafumi ; Wada, Kentaro ; Sutani, Shinya ; Umezawa, Rei ; Maemoto, Hitoshi ; Ii, Noriko ; Kawamura, Tomoko ; Ikushima, Hitoshi ; Takenaka, Ryosuke ; Konishi, Koji ; Yorozu, Atsunori ; Jingu, Keiichi ; Ariga, Takuro ; Nomoto, Yoshihito ; Yamashita, Hideomi</creatorcontrib><description>To assess the feasibility of external beam radiotherapy without central shielding in definitive radiotherapy for Japanese patients with cervical cancer. We retrospectively analysed the data of cervical cancer patients treated with definitive radiotherapy consisting of external beam radiotherapy without central shielding and three-dimensional-image-guided brachytherapy. The study included 167 patients (T1 + 2 = 108, T3 + 4 = 59) from eight Japanese institutions. For three-dimensional-image-guided brachytherapy, intra-cavitary and interstitial brachytherapy was utilized in 33 patients (20%). The median follow-up was 26.6 months (interquartile range, 20-43.2). The maximum rectal D2 (75 Gy)/bladder D2 (90 Gy) constraints were deviated by 6%/10% and 10%/5% for T1 + 2 and T3 + 4, respectively. The 2-year incidence of ≥grade 3 proctitis/cystitis was 4%/1% for T1 + 2 and 10%/2% for T3 + 4. The 2-year local progression-free survival was 89% for T1 + 2 and 82% for T3 + 4. For T1 + 2, the 2-year local progression-free survival for the high-risk clinical target volume D90 ≥ 68 Gy (indicated by receiver operating characteristic analysis; area under the curve = 0.711) was 92% versus 67% for &lt;68 Gy (log-rank; P = 0.019). Cox multivariate analysis indicated that the high-risk clinical target volume D90 was one of independent predictors of local failure (P = 0.0006). For T3 + 4, the 2-year local progression-free survival was 87% for the high-risk clinical target volume &lt;82 cm3 (area under the curve = 0.67) and 43% for ≥82 cm3 (P = 0.0004). Only the high-risk clinical target volume was an independent predictor of local failure (P = 0.0024). Definitive radiotherapy consisting of external beam radiotherapy without central shielding and three-dimensional-image-guided brachytherapy was feasible for Japanese patients with cervical cancer. Dose de-escalation from the current global standards is suggested for patients with T1 + 2 disease.</description><identifier>ISSN: 1465-3621</identifier><identifier>EISSN: 1465-3621</identifier><identifier>DOI: 10.1093/jjco/hyad022</identifier><identifier>PMID: 36974716</identifier><language>eng</language><publisher>England</publisher><subject>Brachytherapy ; East Asian People ; Feasibility Studies ; Female ; Humans ; Radiotherapy Dosage ; Radiotherapy, Image-Guided ; Retrospective Studies ; Treatment Outcome ; Uterine Cervical Neoplasms - radiotherapy</subject><ispartof>Japanese journal of clinical oncology, 2023-06, Vol.53 (6), p.480-488</ispartof><rights>The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c347t-9f927870e3c74328977c096c4e4ec4efacbbd83083b885b20207840b6f13bcf73</citedby><cites>FETCH-LOGICAL-c347t-9f927870e3c74328977c096c4e4ec4efacbbd83083b885b20207840b6f13bcf73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36974716$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Toita, Takafumi</creatorcontrib><creatorcontrib>Wada, Kentaro</creatorcontrib><creatorcontrib>Sutani, Shinya</creatorcontrib><creatorcontrib>Umezawa, Rei</creatorcontrib><creatorcontrib>Maemoto, Hitoshi</creatorcontrib><creatorcontrib>Ii, Noriko</creatorcontrib><creatorcontrib>Kawamura, Tomoko</creatorcontrib><creatorcontrib>Ikushima, Hitoshi</creatorcontrib><creatorcontrib>Takenaka, Ryosuke</creatorcontrib><creatorcontrib>Konishi, Koji</creatorcontrib><creatorcontrib>Yorozu, Atsunori</creatorcontrib><creatorcontrib>Jingu, Keiichi</creatorcontrib><creatorcontrib>Ariga, Takuro</creatorcontrib><creatorcontrib>Nomoto, Yoshihito</creatorcontrib><creatorcontrib>Yamashita, Hideomi</creatorcontrib><title>Definitive radiotherapy consisting of external beam radiotherapy without central shielding and 3D image-guided brachytherapy for patients with cervical cancer: feasibility for Japanese patients and dose-response analyses for local control in the low-dose range</title><title>Japanese journal of clinical oncology</title><addtitle>Jpn J Clin Oncol</addtitle><description>To assess the feasibility of external beam radiotherapy without central shielding in definitive radiotherapy for Japanese patients with cervical cancer. We retrospectively analysed the data of cervical cancer patients treated with definitive radiotherapy consisting of external beam radiotherapy without central shielding and three-dimensional-image-guided brachytherapy. The study included 167 patients (T1 + 2 = 108, T3 + 4 = 59) from eight Japanese institutions. For three-dimensional-image-guided brachytherapy, intra-cavitary and interstitial brachytherapy was utilized in 33 patients (20%). The median follow-up was 26.6 months (interquartile range, 20-43.2). The maximum rectal D2 (75 Gy)/bladder D2 (90 Gy) constraints were deviated by 6%/10% and 10%/5% for T1 + 2 and T3 + 4, respectively. The 2-year incidence of ≥grade 3 proctitis/cystitis was 4%/1% for T1 + 2 and 10%/2% for T3 + 4. The 2-year local progression-free survival was 89% for T1 + 2 and 82% for T3 + 4. For T1 + 2, the 2-year local progression-free survival for the high-risk clinical target volume D90 ≥ 68 Gy (indicated by receiver operating characteristic analysis; area under the curve = 0.711) was 92% versus 67% for &lt;68 Gy (log-rank; P = 0.019). Cox multivariate analysis indicated that the high-risk clinical target volume D90 was one of independent predictors of local failure (P = 0.0006). For T3 + 4, the 2-year local progression-free survival was 87% for the high-risk clinical target volume &lt;82 cm3 (area under the curve = 0.67) and 43% for ≥82 cm3 (P = 0.0004). Only the high-risk clinical target volume was an independent predictor of local failure (P = 0.0024). Definitive radiotherapy consisting of external beam radiotherapy without central shielding and three-dimensional-image-guided brachytherapy was feasible for Japanese patients with cervical cancer. Dose de-escalation from the current global standards is suggested for patients with T1 + 2 disease.</description><subject>Brachytherapy</subject><subject>East Asian People</subject><subject>Feasibility Studies</subject><subject>Female</subject><subject>Humans</subject><subject>Radiotherapy Dosage</subject><subject>Radiotherapy, Image-Guided</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><subject>Uterine Cervical Neoplasms - radiotherapy</subject><issn>1465-3621</issn><issn>1465-3621</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpVkUtv1DAUhQMqog_YsUZesiDUsZM4YYdaXlWlbmAd-XE98chjB9tpyb_HmZkC3djW1XfOvdenKN5U-EOFe3q53Up_OS5cYUKeF2dV3TYlbUl18t_7tDiPcYsxbrqavSxOaduzmlXt2bOTa9DGmWTuAQWujE8jBD4tSHoXTUzGbZDXCH4nCI5bJIDvnoIPJo1-TkiCSyETcTRg1arjTiF6jcyOb6DczEaBQiJwOS6PWu0DmngyWRr3Rtkl3BuZbSR3-f0RaeDRCGNNOuA3fOIOIvzTrW2Uj1AGiFOeGnKF2yVC3Aus39v5PJ23yDiUm-fiQ7lq8ipuA6-KF5rbCK-P90Xx88vnH1ffytu7r9-vPt2WktYslb3uCesYBipZTUnXMyZx38oaasiH5lII1VHcUdF1jSCYYNbVWLS6okJqRi-KdwffKfhfM8Q07EyUYG3eyM9xIB2pWto3TZ3R9wdUBh9jAD1MIX9kWIYKD2vuw5r7cMw942-PzrPYgfoLPwZN_wD2zbIm</recordid><startdate>20230601</startdate><enddate>20230601</enddate><creator>Toita, Takafumi</creator><creator>Wada, Kentaro</creator><creator>Sutani, Shinya</creator><creator>Umezawa, Rei</creator><creator>Maemoto, Hitoshi</creator><creator>Ii, Noriko</creator><creator>Kawamura, Tomoko</creator><creator>Ikushima, Hitoshi</creator><creator>Takenaka, Ryosuke</creator><creator>Konishi, Koji</creator><creator>Yorozu, Atsunori</creator><creator>Jingu, Keiichi</creator><creator>Ariga, Takuro</creator><creator>Nomoto, Yoshihito</creator><creator>Yamashita, Hideomi</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20230601</creationdate><title>Definitive radiotherapy consisting of external beam radiotherapy without central shielding and 3D image-guided brachytherapy for patients with cervical cancer: feasibility for Japanese patients and dose-response analyses for local control in the low-dose range</title><author>Toita, Takafumi ; Wada, Kentaro ; Sutani, Shinya ; Umezawa, Rei ; Maemoto, Hitoshi ; Ii, Noriko ; Kawamura, Tomoko ; Ikushima, Hitoshi ; Takenaka, Ryosuke ; Konishi, Koji ; Yorozu, Atsunori ; Jingu, Keiichi ; Ariga, Takuro ; Nomoto, Yoshihito ; Yamashita, Hideomi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c347t-9f927870e3c74328977c096c4e4ec4efacbbd83083b885b20207840b6f13bcf73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Brachytherapy</topic><topic>East Asian People</topic><topic>Feasibility Studies</topic><topic>Female</topic><topic>Humans</topic><topic>Radiotherapy Dosage</topic><topic>Radiotherapy, Image-Guided</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><topic>Uterine Cervical Neoplasms - radiotherapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Toita, Takafumi</creatorcontrib><creatorcontrib>Wada, Kentaro</creatorcontrib><creatorcontrib>Sutani, Shinya</creatorcontrib><creatorcontrib>Umezawa, Rei</creatorcontrib><creatorcontrib>Maemoto, Hitoshi</creatorcontrib><creatorcontrib>Ii, Noriko</creatorcontrib><creatorcontrib>Kawamura, Tomoko</creatorcontrib><creatorcontrib>Ikushima, Hitoshi</creatorcontrib><creatorcontrib>Takenaka, Ryosuke</creatorcontrib><creatorcontrib>Konishi, Koji</creatorcontrib><creatorcontrib>Yorozu, Atsunori</creatorcontrib><creatorcontrib>Jingu, Keiichi</creatorcontrib><creatorcontrib>Ariga, Takuro</creatorcontrib><creatorcontrib>Nomoto, Yoshihito</creatorcontrib><creatorcontrib>Yamashita, Hideomi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Japanese journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Toita, Takafumi</au><au>Wada, Kentaro</au><au>Sutani, Shinya</au><au>Umezawa, Rei</au><au>Maemoto, Hitoshi</au><au>Ii, Noriko</au><au>Kawamura, Tomoko</au><au>Ikushima, Hitoshi</au><au>Takenaka, Ryosuke</au><au>Konishi, Koji</au><au>Yorozu, Atsunori</au><au>Jingu, Keiichi</au><au>Ariga, Takuro</au><au>Nomoto, Yoshihito</au><au>Yamashita, Hideomi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Definitive radiotherapy consisting of external beam radiotherapy without central shielding and 3D image-guided brachytherapy for patients with cervical cancer: feasibility for Japanese patients and dose-response analyses for local control in the low-dose range</atitle><jtitle>Japanese journal of clinical oncology</jtitle><addtitle>Jpn J Clin Oncol</addtitle><date>2023-06-01</date><risdate>2023</risdate><volume>53</volume><issue>6</issue><spage>480</spage><epage>488</epage><pages>480-488</pages><issn>1465-3621</issn><eissn>1465-3621</eissn><abstract>To assess the feasibility of external beam radiotherapy without central shielding in definitive radiotherapy for Japanese patients with cervical cancer. We retrospectively analysed the data of cervical cancer patients treated with definitive radiotherapy consisting of external beam radiotherapy without central shielding and three-dimensional-image-guided brachytherapy. The study included 167 patients (T1 + 2 = 108, T3 + 4 = 59) from eight Japanese institutions. For three-dimensional-image-guided brachytherapy, intra-cavitary and interstitial brachytherapy was utilized in 33 patients (20%). The median follow-up was 26.6 months (interquartile range, 20-43.2). The maximum rectal D2 (75 Gy)/bladder D2 (90 Gy) constraints were deviated by 6%/10% and 10%/5% for T1 + 2 and T3 + 4, respectively. The 2-year incidence of ≥grade 3 proctitis/cystitis was 4%/1% for T1 + 2 and 10%/2% for T3 + 4. The 2-year local progression-free survival was 89% for T1 + 2 and 82% for T3 + 4. For T1 + 2, the 2-year local progression-free survival for the high-risk clinical target volume D90 ≥ 68 Gy (indicated by receiver operating characteristic analysis; area under the curve = 0.711) was 92% versus 67% for &lt;68 Gy (log-rank; P = 0.019). Cox multivariate analysis indicated that the high-risk clinical target volume D90 was one of independent predictors of local failure (P = 0.0006). For T3 + 4, the 2-year local progression-free survival was 87% for the high-risk clinical target volume &lt;82 cm3 (area under the curve = 0.67) and 43% for ≥82 cm3 (P = 0.0004). Only the high-risk clinical target volume was an independent predictor of local failure (P = 0.0024). Definitive radiotherapy consisting of external beam radiotherapy without central shielding and three-dimensional-image-guided brachytherapy was feasible for Japanese patients with cervical cancer. Dose de-escalation from the current global standards is suggested for patients with T1 + 2 disease.</abstract><cop>England</cop><pmid>36974716</pmid><doi>10.1093/jjco/hyad022</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1465-3621
ispartof Japanese journal of clinical oncology, 2023-06, Vol.53 (6), p.480-488
issn 1465-3621
1465-3621
language eng
recordid cdi_proquest_miscellaneous_2821639554
source Oxford University Press:Jisc Collections:OUP Read and Publish 2024-2025 (2024 collection) (Reading list)
subjects Brachytherapy
East Asian People
Feasibility Studies
Female
Humans
Radiotherapy Dosage
Radiotherapy, Image-Guided
Retrospective Studies
Treatment Outcome
Uterine Cervical Neoplasms - radiotherapy
title Definitive radiotherapy consisting of external beam radiotherapy without central shielding and 3D image-guided brachytherapy for patients with cervical cancer: feasibility for Japanese patients and dose-response analyses for local control in the low-dose range
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T11%3A31%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Definitive%20radiotherapy%20consisting%20of%20external%20beam%20radiotherapy%20without%20central%20shielding%20and%203D%20image-guided%20brachytherapy%20for%20patients%20with%20cervical%20cancer:%20feasibility%20for%20Japanese%20patients%20and%20dose-response%20analyses%20for%20local%20control%20in%20the%20low-dose%20range&rft.jtitle=Japanese%20journal%20of%20clinical%20oncology&rft.au=Toita,%20Takafumi&rft.date=2023-06-01&rft.volume=53&rft.issue=6&rft.spage=480&rft.epage=488&rft.pages=480-488&rft.issn=1465-3621&rft.eissn=1465-3621&rft_id=info:doi/10.1093/jjco/hyad022&rft_dat=%3Cproquest_cross%3E2821639554%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c347t-9f927870e3c74328977c096c4e4ec4efacbbd83083b885b20207840b6f13bcf73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2821639554&rft_id=info:pmid/36974716&rfr_iscdi=true